prod:prod_dcx-login
Seguir
Compartir
Lectura de 5 minutos
27 de marzo de 2026
SALUD COMUNITARIA Y GLOBAL
Artículo
Hepatitis C Elimination in the U.S. is Within Reach, Experts Report
Hepatitis C elimination in the U.S. is within reach—if we do three things: expand point‑of‑care testing, scale treatment access, and unify stakeholders for coordinated action, according to health economists Louis Garrison, Ph.D. and Bruce Wang, Ph.D.
In a Viewpoint paper in JAMA Health Forum, the economists detail progress toward HCV elimination, including why "single-step HCV diagnosis is widely seen as a critical component of an HCV elimination program"1 and why U.S. policy makers should support the Cure Hepatitis C Act of 2025 (S.1941).
At Cepheid, we’re proud to support HCV elimination efforts by offering the Xpert® HCV test, which provides point‑of‑care molecular detection to help expand access to diagnosis.
Read the full paper JAMA Health Forum.
IVD. Producto sanitario para diagnóstico in vitro. Es posible que no esté disponible en todos los países.
1 Garrison LP, Wang BCM. Stakeholder Engagement for Hepatitis C Virus Elimination. JAMA Health Forum. 2026;7(1):e256433. doi:10:1001/jamahealthforum.2025:6433
Leer siguiente
MÁS
